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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not in adult 
patients with PC-BPPV, is the Semont Maneuver effective in reducing symptoms of vertigo?   
 
STUDY DESIGN: Review of three published, randomized controlled trials (two double-blind 
and one single blinded), all English language.  
 
DATA SOURCES: The three randomized controlled trials that were used for this review were 
found using PubMed and Medline. Articles were selected based on relevance and that the 
outcomes were patient oriented.  
 
OUTCOME(S) MEASURED: Dix-Hallpike Test performed before and after the Semont 
Maneuver to asses nystagmus and questionnaires/self reported symptom status after the Semont 
Maneuver to asses resolution of vertigo.  
 
RESULTS: Mandala et al. and Chen et al. compared the Semont Maneuver to a Sham treatment. 
Salvinelli et al. compared the Semont Maneuver to a no treatment group. All three studies 
demonstrated statistically significant improvement in patient’s vertigo after receiving the Semont 
Maneuver compared to other treatment strategies. Salvinelli et al. demonstrated that cure rates 
with the Semont Maneuver (94.2%) were significantly higher and more effective than the no 
treatment group (35.4%). Mandala et al. determined that at the 1 hr and 24 hr follow up, 79.3% 
and 86.8% of subjects undergoing the Semont Maneuver recovered from vertigo, respectively. 
Chen et al. concluded that on the fourth day, 84.62% of patients being treated with the Semont 
Maneuver showed complete resolution of vertigo symptoms compared to 14.29% of patients 
receiving Sham treatment.  
 
CONCLUSIONS: The results of these three randomized controlled trials suggest that the Semont 
Maneuver is a safe, easily performed, and effective treatment modality for patients with PC-
BPPV.  
 
KEY WORDS: BPPV, Semont Maneuver 
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INTRODUCTION 
Benign Paroxysmal Positional Vertigo (BPPV) is a disorder of the inner ear that is caused 
by free-floating calcium carbonate crystals (otoconia) that are displaced from the macula of the 
utriculus and enter the semicircular canals. The posterior semicircular canal is most commonly 
affected, occasionally the lateral semicircular canal, and rarely the anterior semicircular canal. 
Movement of otoconia within the semicircular canals causes variations in the endolymphatic 
pressure, which is manifested in a patient as vertigo and nystagmus. BPPV is the most common 
form of positional vertigo and is the most common vestibular disease. 1 Its prevalence increases 
with age but is often underestimated in older adults. In a study involving the geriatric population, 
it was found that of the 77% of subjects that had a balance disorder, 9% had BPPV.2 It has been 
estimated from physician data, laboratory data, and failed treatment costs that each patient with 
BPPV spends $2009.63 in health care costs.3 In the United States, BPPV accounts for 18% of 
visits to dizziness clinics each year.4 
 Being able to correctly diagnose BPPV and identify the cause is essential to the effective 
treatment of the condition. The majority of cases of BPPV are idiopathic and are thought to be 
triggered by a change in head position such as lying down, getting up, or rolling over in bed. 
However, some of the identifiable causes of BPPV include Vestibular Neuronitis, Meniere 
Disease, inner ear ischemia, trauma, surgery, and whiplash injuries. 5 
 The standard treatment for patients with BPPV is a particle-repositioning maneuver. The 
most well-known and commonly used maneuvers include the Epley and Modified Epley 
Maneuvers.6 Patients with BPPV are often educated to perform Brandt-Daroff exercises during 
an attack in order to end the symptoms of vertigo, however these exercises are less effective in 
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relieving symptoms than particle-repositioning maneuvers.7 Pharmacologic therapy is not useful 
for brief episodes of vertigo associated with BPPV. However, vestibular suppressants may be 
helpful in patients who have difficulty tolerating particle-repositioning maneuvers due to 
discomfort and nausea. Betahistine is commonly given and rarely is Meclizine used.8  
 Currently, particle-repositioning remains the therapy of choice in the treatment of BPPV. 
The Semont Maneuver is an additional particle-repositioning maneuver that may be used to 
improve vertigo symptoms in patients with posterior canal BPPV (PC-BPPV).   
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not in adult 
patients with PC-BPPV, is the Semont Maneuver effective in reducing symptoms of vertigo.  
METHODS 
 All three studies selected for this review focused on a population of adult (> 18 y/o) 
patients with clinically diagnosed PC-BPPV. The intervention under investigation is the Semont 
Maneuver versus the comparison groups of Sham treatment and no treatment. All three studies 
measured improvement of vertigo symptoms subjectively by questionnaires/self reported 
symptom status and objectively by patients’ response (nystagmus) to Dix-Hallpike testing. Two 
of the studies chosen for this review were double-blinded randomized controlled trials and one of 
the studies was a single-blinded randomized controlled trial.  
 The author completed a search using PubMed and Medline web databases using key 
words “Benign Paroxysmal Positional Vertigo” and “Semont Maneuver.” All three articles were 
published in English between 2004 and 2012 in peer-reviewed journals. The studies were 
selected based on their relevance to the clinical question and focused on outcomes that were 
patient oriented (POEMs).  
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 Inclusion criteria included studies that were randomized controlled trials published after 
1999 that focused on patient oriented outcomes (POEMs). Subjects selected were adult (> 18 
y/o) patients with diagnosed unilateral PC-BPPV via Dix-Hallpike Testing. Exclusion criteria 
included patients < 18 y/o and patients with lateral or anterior semicircular canal BPPV. 
Summary of statistics reported or used include P-values and mean change from baseline.  
OUTCOMES MEASURED 
 The outcome measured in all three studies was improvement of vertigo symptoms. After 
the Semont Maneuver was performed, the outcome was assessed subjectively by 
questionnaires/self reported symptom status and objectively by patients’ response (nystagmus) to 
Dix-Hallpike testing. Successful treatment was defined as a negative Dix-Hallpike test and 
absence of vertigo.  
RESULTS 
 All three studies were randomized controlled trials that evaluated the efficacy of the 
Semont Maneuver compared to either Sham or no treatment groups. The clinical and 
demographic baseline characteristics were not significantly different between the two groups 
being compared in all three studies. Each study utilized dichotomous data with intention-to-treat 
analysis. The relative benefit increase (RBI), absolute benefit increase (ABI), and numbers 
needed to treat (NNT) were calculated using efficacy rates from the Semont Maneuver, Sham 
treatment, and no treatment groups. These values were derived from experimental event rate 
(EER) and controlled event rate (CER) using clinical success percentages defined as resolution 
of vertigo. In each study, all patients completed the therapy and none were lost during the follow 
up period.  
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Table 1: Demographics & Characteristics of included studies 
Study Type # Pts Age (yrs) Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Chen 
(2012) 8 
RCT 128 Semont 
Group: 
53.55 yrs ± 
9.91 yrs 
Sham 
Group: 
52.35 yrs ± 
8.55 yrs 
- Pts with 
symptoms 
of unilateral 
PC-BPPV 
and 
diagnosed 
via Dix-
Hallpike 
Test.  
 
- Pts with 
bilateral PC-
BPPV or 
traumatic 
BPPV.  
- Pts with 
BPPV lasting 
> 2 months 
- Pts with 
horizontal or 
anterior canal 
BPPV 
0 - Semont 
Maneuver 
Salvinelli 
(2004) 9 
RCT 156 Semont 
Group: mean 
= 73 yrs 
(range = 70-
78 yrs) 
No Tx 
Group: mean 
= 75 yrs 
(range = 72-
79 yrs) 
  
- Pts with 
diagnosed 
PC-BPPV 
according to 
Dix-
Hallpike 
Test.  
- Pts with 
asymmetrical 
hearing loss 
- Pts with 
neurological 
diseases 
- Pts with 
poor general 
health 
conditions 
- Pts with an 
abnormal BP 
- Pts who 
have used 
Ototoxic 
drugs 
0 - Semont 
Maneuver 
Mandala 
(2012) 10 
RCT 342 Semont 
Group: 62.1 
yrs ± 15.1 
yrs 
Sham 
Group: 63.9 
yrs ± 16.2 
yrs 
- Pts with 
diagnosed 
unilateral 
PC-BPPV 
according to 
Dix-
Hallpike 
Test.  
- Pts with 
bilateral PC-
BPPV 
- Pts with 
multiple canal 
atypical 
positional 
nystagmus 
- Pts 
previously 
treated with 
repositioning 
maneuvers 
0 - Semont 
Maneuver 
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In Mandala et al, a total of 342 adult (> 18 y/o) patients with diagnosed unilateral PC-
BPPV via Dix-Hallpike testing were recruited from 7 Otoneurology units in Italy. Excluded from  
the study were patients with bilateral PC-BPPV, multiple canal atypical positional nystagmus, or 
patients previously treated with repositioning maneuvers. Patients were randomized into a 
treatment group by Semont Maneuver or Sham treatment. Sham treatment consisted of 
performing the Semont Maneuver but for the unaffected ear. The Semont Maneuver and Sham 
treatments were performed once and patients were assessed at 1 hr and 24 hrs. Patients in both 
groups whose symptoms of BPPV hadn’t resolved at the 24 hr follow up were treated with the 
Semont Maneuver. Patients were followed for 2 weeks and were instructed to return to the 
hospital if BPPV symptoms persisted or reoccurred to be treated again with the Semont 
Maneuver. 86.8 % of patients receiving the Semont Maneuver had complete resolution of 
symptoms at 24 hrs post intervention compared to 0.00% in the Sham treatment group. When 
comparing the two groups, the Semont Maneuver group was statistically more effective than the 
Sham treatment group (P < 0.0001). The results are summarized in Table 2. 
 Table 2: Semont Maneuver vs Sham Treatment at 24 hrs.  
 CER EER RBI ABI NNT P-Value 
% Cure 
Rate 0.00 0.868 1.00 0.868 2 < 0.0001 
 
 In Salvinelli et al, 156 adult (> 18 y/o) patients were selected after being diagnosed with 
unilateral PC-BPPV via Dix-Hallpike testing. Subjects were enrolled at the Department of 
Otolaryngology of Campus Bio Medico University in Rome, Italy. Patients excluded from the 
study had a history of asymmetrical hearing loss, neurological disease, poor general health 
conditions, abnormal blood pressure, and prior use of ototoxic drugs. Patients with BPPV were 
randomized into either a Semont Maneuver group or no treatment group. Patients in the Semont 
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Maneuver group were treated one to three times at 1-week intervals until resolution of their 
symptoms. At the end of each treatment, a 6-month follow-up was performed. In the Semont 
Maneuver group, 94.2% of patients had a resolution of symptoms after 3 sessions of Semont 
Maneuver compared to only 34.6% in the no treatment group. When comparing the two groups, 
the Semont Maneuver group was statistically more effective than the no treatment group (P < 
0.001). The results are summarized in Table 3.  
Table 3: Semont Maneuver vs No Treatment after 3 sessions.  
 CER EER RBI ABI NNT P-Value 
% Cure 
Rate 0.346 0.942 1.72 0.596 2 < 0.001 
 
 In the Chen et al. study, 128 adult (> 18 y/o) patients with unilateral PC-BPPV were 
enrolled from the neurology outpatient clinic at Changzheng Hospital. Patients were diagnosed 
after having undergone bedside vestibular testing, including the Dix-Hallpike test, Rinne test, 
Weber test, Romberg’s test, positional test, and a Fukuda test. Patients excluded from the study 
had bilateral PC-BPPV, traumatic BPPV, BPPV lasting more than 2 months, or BPPV involving 
the horizontal or anterior semicircular canals. Patients were randomized into a treatment group 
by Semont Maneuver or a Sham treatment group. In the Semont Maneuver group, treatment was 
repeated until resolution of symptoms or until 4 maneuvers had been performed. Sham treatment 
consisted of a Semont Maneuver but for the unaffected side. Patients in both groups received 
treatment with the Semont Maneuver if they hadn’t significantly improved by the fourth day. On 
the fourth day after treatment, 84.62% of patients in the Semont Maneuver group were free of 
symptoms compared to 14.29% in the Sham group. There was significant difference in the cure 
rate between the two groups (P < 0.001). The results are summarized in Table 4. 
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Table 4: Semont Maneuver vs Sham Treatment at day 4.   
 CER EER RBI ABI NNT P-Value 
% Cure 
Rate 0.1429 0.8462 4.92 0.7033 2 < 0.001 
 
DISCUSSION 
This systematic review analyzed three randomized controlled trials to determine if the 
Semont Maneuver is effective in the treatment of vertigo. Overall, the data demonstrates that the 
Semont Maneuver is effective in resolving symptoms of vertigo in patients with PC-BPPV. All 
three studies showed statistical significance.  
In 1983, Alain Semont presented a new therapeutic technique for the treatment of PC-
BPPV known as the Semont Maneuver. It is an easily and quickly performed maneuver that can 
be performed at a patient’s bedside as part of a clinician’s routine examination. In combination 
with the Dix-Hallpike Test, patients with PC-BPPV can be diagnosed and treated at bedside 
without the use of blood work or radiographic studies. Many practitioners recommend the use of 
IR video goggles for monitoring eye movement during positioning, but this equipment is not 
necessary to accurately diagnose and treat PC-BPPV.9 Thus, the Semont Maneuver is highly cost 
effective and no special equipment is needed.9 It is recommended that every general practitioner 
and geriatrician be able to use this maneuver to provide relief of patient’s symptoms.10  
Currently there are no absolute contraindications to use this therapeutic treatment; 
however, relative contraindications include any orthopedic condition that limits patient mobility 
due to the brisk movement that occurs during the maneuver.10 When performing this maneuver, 
there is a chance that free-floating particles may enter another canal, most commonly from the 
posterior to the horizontal semicircular canal. This most likely occurs when the head is brought 
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upright but not maintained in the proper position.9 Common minor side effects that may be 
experienced include nausea, vomiting, loss of balance, pallor, and sweating.11  
Various limitations existed in the three randomized clinical trials. In Salvinelli et al, the 
study was only single blinded and thus the results may have been subject to bias by the un-
blinded investigator who performed the Dix-Hallpike testing both before and after the 
intervention. In both Chen et al. and Salvinelli et al, patients were recruited from a single 
Hospital whereas in Mandala et al patients were recruited from 7 Otoneurology units throughout 
Italy. A larger demographic population may have helped increase the strength of the results. In 
Mandala et al. and Chen et al, each study had short-term follow up periods of 2 weeks and a few 
days respectively, which hinders the strength of their findings.  
CONCLUSION 
 In conclusion, this systematic review of three randomized controlled trials demonstrates 
that the Semont Maneuver is effective in the treatment of PC-BPPV. The data collected in all 
three studies showed statistical significance in improving patient’s symptoms of vertigo. Particle-
repositioning remains the therapy of choice for the treatment of PC-BPPV and this new body of 
evidence suggests that the Semont Maneuver be strongly considered as a first line therapy in 
patients with PC-BPPV. Further studies evaluating the relapse rates of the Semont Maneuver are 
warranted. Lastly, a systematic review comparing the efficacy of the two most common particle-
repositioning maneuvers, Epley and Semont, is warranted. 
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